P. Wong et Wh. Burgess, FGF2-HEPARIN CO-CRYSTAL COMPLEX-ASSISTED DESIGN OF MUTANTS FGF1 AND FGF7 WITH PREDICTABLE HEPARIN AFFINITIES, The Journal of biological chemistry, 273(29), 1998, pp. 18617-18622
The co-crystal structures of FGF2 and heparin derived tetra- and hexas
accharides demonstrated the existence of high and low affinity contact
residues that are likely to be involved in heparin binding (Faham, S.
, Hileman, R, E., Fromm, J. R., Linhardt, R. J., and Rees, D. C. (1996
) Science 271, 1116-1120), To study the role of these putative contact
residues, me chose three fibroblast growth factor family members with
distinct heparin affinities for comparative mutagenesis studies. Only
one amino acid significantly differed between FGF1 and FGF2 and was m
utated, FGF1-31K. FGF7, also called keratinocyte growth factor, was mu
tated to mimic either FGF1 or FGF2 at two of the putative high contact
points termed FGF7-1 and FGF7-2, respectively, FGF2 has higher appare
nt heparin affinity than FGF1 or FGF7, and FGF1 has higher heparin aff
inity than FGF7, All three mutants showed an increase in apparent hepa
rin affinity compared with wild types, FGF7-1 has a lower apparent hep
arin affinity than FGF7-2, analogous to wild type FGF1 and FGF2, The F
GF1-31K mutant showed no change in mitogenic activity, whereas the FGF
7 mutants exhibited a decrease in activity, These results indicate tha
t the co-crystal structure of the FGF2-heparin complexes can be used t
o design a rational approach to the generation of mutants with defined
affinities for heparin or heparan sulfate proteoglycans.